Sponsored Links
BioCryst Pharmaceuticals Incorporated
News and Blogs

Total : 1 View more »
BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
www.bioportfolio.co.uk | Oct 26, 2008
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory
Web Sites

Total : 21 View more »
BCRX: Q3 Earnings Call @ 08:30 ET Today [delayed] - Zibb.com
www.zibb.com
Biocryst Pharmaceuticals, Inc. (Nasdaq NM : BCRX) will host a conference call to discuss its Q3 2008 financial results. Call Details When : Friday, October 31, 2008 Webcast : Click Here to Listen Phone # : 800-860-2442 Intl # : 412-858-4600 Source: Company Press Release GET KNOBIAS IN REAL-TIME:
http://www.zibb.com/article/4282652/BCRX+Q+Earnings+Call+ET+Today+delayed
Avigen
Zola Horovitz, Ph.D., Chairman of the Board, has served as a director of Avigen since November 1994. Dr. Horovitz has been an independent consultant to pharmaceutical and biotechnology companies since May 1994. From 1991 to May 1994, Dr.
BCRX - BioCryst Pharmaceuticals, Inc. Stock Quotes, News, Stock Charts, Report ...
Stock earnings, recommendations and SEC filings for BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals - Analyst News | newratings.com
Copyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.
http://www.newratings.com/headlines/BioCryst-Pharmaceuticals_US09058V1035.html
News from Zibb.com
Total : 4 View more »
BioCryst Pharmaceuticals, Inc. (BCRX) Corporate Event Announcement Notice - Zibb.com
Oct 31, 2008 (Wall Street Horizon via COMTEX) --
BioCryst Pharmaceuticals, Inc. (BCRX)
Expected next earnings release: Announcement date: 10/31/2008 - Before Market Earnings Quarter: Q3 Announcement Status: Verified
Expected next investor conference call information: Conference Call Date: 10/31/2008 Conference Call Time: 8:30 AM Conference Call URL: http://investor.shareholder.com/biocryst/
Tags: conference corporate earnings market pharmaceuticals
Companies: BioCryst Pharmaceuticals, Inc. (BCRX)
Equedia: Analyst Consensus and Insider Trades for CuraGen Corporation - Zibb.com
Nov 03, 2008 (M2 PRESSWIRE via COMTEX) --
From the world's business leaders to top market professionals, Equedia.com takes you straight to the people behind today's most important business stories - that includes you!
Today, November 3, 2008 we're focusing on CuraGen Corporation (Nasdaq: CRGN), after they reported its financial results for the third quarter of 2008. During the three month period ended September 30, 2008, CuraGen utilized $3.6 million of cash for operations and ended the quarter with $91.4 million of cash and investments. CuraGen expects to utilize an average of $3 to $4 million of cash per quarter through June 2009. The company expects to end the fourth quarter of 2008 with approximately $87 to $89 million in cash and investments, and end the second quarter of 2009 with approximately $79 to $81 million in cash and investments. CuraGen is also pursuing partnership opportunities around CR011-vcMMAE.
Visit http://equedia.com/login.php and register free for more news, investor coverage, videos, and comprehensive market overviews including analyst overviews, insider trades, earnings reports, filings, financials, plus much more on CuraGen Corporation
We ask that shareholders of CuraGen Corporation join and participate in our investment network to provide prospective shareholders more insight and share any information with our investors. Please register at http://equedia.com/login.php for more investor coverage and related business videos on other companies.
ABOUT CURAGEN CORPORATION
CuraGen Corporation (Nasdaq: CRGN) is a clinical-stage biopharmaceutical company developing promising approaches for the treatment of cancer. CuraGen Corporation is headquartered in Branford, Connecticut.
ABOUT EQUEDIA
Equedia.com is a human-powered investment search portal and a platform for users to share financial videos & information through a social web experience. We provide corporations with free online investor relations and syndicate business media through user-generated content. Unlike traditional finance portals, we give users the ability to add, edit and update videos, content, and presentations, thus creating an atmosphere unlike traditional portals.
Investments are more than just filings & news. Most finance portals have data, stats, & news but little of it is meaningful & difficult for most to understand. Does the average investor know what EBITA means?
A lot more happens and affects corporations than what we see on press releases and statistical data. Using video & user generated content, we go deeper into a story behind a company, giving investors the context they need to understand their investments. The information provided is created by parties from all different perspectives thus adding value to the content.
As an investor, can you really follow the news 24/7 or keep up with all of the third party opinions on the stocks you own? With the help of investors, business media, and corporations, Equedia provides a portal to do just that.
EQUEDIA FOR INVESTORS
Manage your investment life! From the world's business leaders to top market professionals, Equedia takes you straight to the people behind today's most important business stories - that includes you!
Not only do we provide the most up-to-date financial information on your investments such as quotes, news, insider trades, history, etc., we connect you with corporations, analysts, business media outlets, and other investors like yourself. We are breaking the barriers of traditional financial blogging and business networking by. Registration is free so sign up now and be part of the action.
Learn more: http://equedia.com/cms.php/about/investor
EQUEDIA FOR PUBLICLY TRADED COMPANIES
Equedia is pioneering the financial video network for online communities of public corporations, investors, brokers, and the media by connecting them through video and rich media across our network. We redefine the world of online investor relations communication by providing an easy-to-use and extremely cost-effective solution for public corporations - most of our services are completely complimentary.
We encourage public companies to participate using our free online investor relations and video presentation services. Learn how to effectively communicate and manage your shareholders online at no cost and give your shareholders the attention they deserve and the presentation you require.
Learn more: http://equedia.com/cms.php/about/companies
EQUEDIA FOR BUSINESS MEDIA
At Equedia, we know how difficult it can be in today's online information distribution of your content. Implemented search engine optimization (SEO) on your website can only go so far. Press releases over stretch budgets and advertising costs are high as ever.But the positives of being online far outweigh the negatives. It gives YOU and your Company much greater exposure to a much greater audience - even more so now with Equedia.
Learn more: http://equedia.com/cms.php/about/media
IMPORTANT:
It is extremely important you understand that this news release is not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction. The material herein was prepared by Equedia Network Corporation (Equedia) based upon information we believed to be reliable. The information contained herein is not guaranteed by Equedia to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion and this opinion may contain forward-looking statements that involve risks and uncertainties. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Equedia undertakes no obligation to update such statements. Equedia is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed or mentioned herein and/or on www.equedia.com.
Please read our full disclaimer at: http://equedia.com/cms.php/terms
CONTACT: Equedia Network Corporation Tel: +1 888 378 3342 e-mail: info@equedia.com WWW: http://www.equedia.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
Tags: advertising advisor annual report broker business cancer clinical connecticut dealer earnings e-mail finance financial results investment market media nasdaq networking online partnership securities video web
Companies: CuraGen Corp. (CRGN)
Equedia: Analyst Consensus and Insider Trades for BioCryst Pharmaceuticals, Inc. - Zibb.com
Oct 31, 2008 (M2 PRESSWIRE via COMTEX) --
From the world's business leaders to top market professionals, Equedia.com takes you straight to the people behind today's most important business stories - that includes you!
Today we're focusing on BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) after they announced today October 31, 2008, their financial results for the quarter ended September 30, 2008. For the three months ended September 30, 2008, the Company reported collaborative and other research and development revenues of $8.9 million compared to $20.5 million for the three months ended September 30, 2007. This decrease is driven by a reduction in peramivir clinical development costs and associated revenue from the contract with the U.S. Department of Health and Human Services (HHS) for the development of peramivir. Currently, the majority of the Company's revenues are derived from the reimbursement of costs under the contract with HHS.
Visit http://equedia.com/login.php and register free for more investor coverage, videos, and comprehensive market overviews including analyst overviews, insider trades, earnings reports, filings, financials, plus much more on BioCryst Pharmaceuticals, Inc.
We ask that shareholders of BioCryst Pharmaceuticals, Inc. to join and participate in our investment network to provide prospective shareholders more insight and share any information with our investors. Please register at http://equedia.com/login.php for more investor coverage and related business videos on other companies.
ABOUT EQUEDIA
Equedia.com is a human-powered investment search portal and a platform for users to share financial videos & information through a social web experience. We provide corporations with free online investor relations and syndicate business media through user-generated content. Unlike traditional finance portals, we give users the ability to add, edit and update videos, content, and presentations, thus creating an atmosphere unlike traditional portals.
Investments are more than just filings & news. Most finance portals have data, stats, & news but little of it is meaningful & difficult for most to understand. Does the average investor know what EBITA means?
A lot more happens and affects corporations than what we see on press releases and statistical data. Using video & user generated content, we go deeper into a story behind a company, giving investors the context they need to understand their investments. The information provided is created by parties from all different perspectives thus adding value to the content.
As an investor, can you really follow the news 24/7 or keep up with all of the third party opinions on the stocks you own? With the help of investors, business media, and corporations, Equedia provides a portal to do just that.
EQUEDIA FOR INVESTORS
Manage your investment life! From the world's business leaders to top market professionals, Equedia takes you straight to the people behind today's most important business stories - that includes you!
Not only do we provide the most up-to-date financial information on your investments such as quotes, news, insider trades, history, etc., we connect you with corporations, analysts, business media outlets, and other investors like yourself. We are breaking the barriers of traditional financial blogging and business networking by. Registration is free so sign up now and be part of the action.
Learn more: http://equedia.com/cms.php/about/investor
EQUEDIA FOR PUBLICLY TRADED COMPANIES
Equedia is pioneering the financial video network for online communities of public corporations, investors, brokers, and the media by connecting them through video and rich media across our network. We redefine the world of online investor relations communication by providing an easy-to-use and extremely cost-effective solution for public corporations - most of our services are completely complimentary.
We encourage public companies to participate using our free online investor relations and video presentation services. Learn how to effectively communicate and manage your shareholders online at no cost and give your shareholders the attention they deserve and the presentation you require.
Learn more: http://equedia.com/cms.php/about/companies
EQUEDIA FOR BUSINESS MEDIA
At Equedia, we know how difficult it can be in today's online information distribution of your content. Implemented search engine optimization (SEO) on your website can only go so far. Press releases over stretch budgets and advertising costs are high as ever.But the positives of being online far outweigh the negatives. It gives YOU and your Company much greater exposure to a much greater audience - even more so now with Equedia.
Learn more: http://equedia.com/cms.php/about/media
IMPORTANT:
It is extremely important you understand that this news release is not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction. The material herein was prepared by Equedia Network Corporation (Equedia) based upon information we believed to be reliable. The information contained herein is not guaranteed by Equedia to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion and this opinion may contain forward-looking statements that involve risks and uncertainties. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Equedia undertakes no obligation to update such statements. Equedia is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed or mentioned herein and/or on www.equedia.com.
Please read our full disclaimer at: http://equedia.com/cms.php/terms
CONTACT: Equedia Network Corporation Tel: +1 888 378 3342 e-mail: info@equedia.com WWW: http://www.equedia.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
Tags: advertising advisor annual report broker business clinical dealer earnings e-mail finance financial results investment market media nasdaq networking online pharmaceuticals research and development revenue securities video web
Companies: BioCryst Pharmaceuticals, Inc. (BCRX)
BioCryst Pharmaceuticals, Inc. (BCRX) Corporate Event Announcement Notice - Zibb.com
Nov 01, 2008 (Wall Street Horizon via COMTEX) --
BioCryst Pharmaceuticals, Inc. (BCRX)
Expected next earnings release: Announcement date: 3/4/2009 - Before Market Earnings Quarter: Q4 Announcement Status: Unconfirmed
Expected next investor conference call information: Conference Call Date: 10/31/2008 Conference Call Time: 8:30 AM Conference Call URL: http://investor.shareholder.com/biocryst/
Tags: conference corporate earnings market pharmaceuticals
Companies: BioCryst Pharmaceuticals, Inc. (BCRX)
News from Zibb.com
- BioCryst Pharmaceuticals, Inc. (BCRX) Corporate Event Announcement Notice - Zibb.com
- Equedia: Analyst Consensus and Insider Trades for CuraGen Corporation - Zibb.com
- Equedia: Analyst Consensus and Insider Trades for BioCryst Pharmaceuticals, Inc. - Zibb.com
- BioCryst Pharmaceuticals, Inc. (BCRX) Corporate Event Announcement Notice - Zibb.com
Explore Related Products
Explore in Related Industries
- BioCryst Pharmaceuticals Incorporated in:
- Healthcare & Medicine (42)
- Finance & Tax (17)
- Information Technology (3)
- Chemicals, Plastics & Rubber (2)
- Construction (1)
Explore Related Topics
- Health
- Medical Science
- Pharmaceutical Science
- Accounting & Finance
- Drug Addiction & Habituation
- Drugs Registration
- Marketing
- Health & Healthcare in General
- Diseases & Conditions
- Copyright
- Patents & Trademarks
- Advertising
